UK Companies House feature
PHARMARON MANUFACTURING SERVICES (UK) LTD
Cash
£2M
-34.6% vs 2023
Net assets
—
Equity attributable
Employees
138
0% vs 2023
Profit before tax
-£16M
-1.6% vs 2023
Profile
- Company number
- 05188033
- Status
- Active
- Incorporation
- 2004-07-23
- Last accounts made up
- 2024-12-31
- Account category
- FULL
- Primary SIC
- 21100
- Hubs
- UK Healthcare
Profit before tax
5-year trend · vs UK Healthcare median
PHARMARON MANUFACTURING SERVICES (UK) LTD
PHARMARON MANUFACTURING SERVICES (UK) LTD
PHARMARON MANUFACTURING SERVICES (UK) LTD
PHARMARON MANUFACTURING SERVICES (UK) LTD
Accounts
5-year trend · latest 2024-12-31
| Metric | Trend | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Turnover | — | — | — | — | — | |
| Operating profit | — | — | — | — | — | |
| Profit before tax | — | — | — | -£16,065,312 | -£16,325,573 | |
| Net profit | — | — | — | — | — | |
| Cash | — | — | — | £2,763,713 | £1,808,106 | |
| Total assets less current liabilities | — | — | — | — | — | |
| Net assets | — | — | — | — | — | |
| Equity | £11,918,921 | £48,215 | £48,215 | £469,741 | -£21,714,470 | |
| Average employees | — | — | — | 138 | 138 | |
| Wages | — | — | — | £6,683,036 | £6,929,919 |
Values shown as filed in iXBRL accounts. — indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Azets Audit Services
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“The directors concluded that the entity requires support from the ultimate parent Company to meet liquidity needs during the going concern period. The Directors have obtained a letter of support from Pharmaron Beijing Co Ltd, confirming willingness to provide financial support. Directors believe the Company has adequate resources to continue in operational existence for the next twelve months.”
Significant events
- “The strategic development of the site has continued in 2024 with the approval of a further ~£3.75m of capital investment in modular configuration and upgrade of technical capabilities.”
- “The Company had negative net assets of £21.7m at the period-end (2023: £25.8m).”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
3 active · 37 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| LEWINTON, Stephen Christopher, Mr. | Secretary | 2022-01-07 | — | — |
| LEWINTON, Stephen Christopher, Mr. | Director | 2022-01-07 | Apr 1966 | British |
| LOU, Boliang, Dr | Director | 2022-01-07 | Sep 1963 | American |
Show 37 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| HAYES, Paul Andrew | Secretary | 2018-02-28 | 2018-09-07 |
| ILETT, John Edward | Secretary | 2015-11-02 | 2018-02-28 |
| JACKSON, Andrew Leonard | Secretary | 2018-09-07 | 2020-04-30 |
| JONES, Nick | Secretary | 2009-11-27 | 2014-11-12 |
| SIMS, Adam Duncan | Secretary | 2004-08-16 | 2009-11-30 |
| WARD, Iain Stuart | Secretary | 2014-11-12 | 2015-11-02 |
| EVERSECRETARY LIMITED | Corporate Nominee Secretary | 2004-07-23 | 2004-08-16 |
| AVERY, Paul John | Director | 2014-11-12 | 2015-11-02 |
| BOERMAN, Manja Hermina Elisabeth Maria, Dr | Director | 2017-05-22 | 2019-11-30 |
| BROWN, Tom | Director | 2004-08-31 | 2009-01-20 |
| COTTON, Richard John | Director | 2014-11-12 | 2016-12-13 |
| DODS, Samuel Charles | Director | 2004-08-16 | 2005-05-11 |
| ELDERED, Thomas Bengt | Director | 2020-02-04 | 2021-04-09 |
| GLENN, Jonathan Martin | Director | 2014-11-12 | 2020-02-04 |
| GOWLAND, Christopher David | Director | 2014-11-12 | 2015-10-30 |
| GOWLAND, Christopher David | Director | 2010-01-01 | 2010-12-31 |
| GOWLAND, Christopher | Director | 2004-08-16 | 2006-10-09 |
| HARDY, Robert, Dr | Director | 2004-08-16 | 2014-11-12 |
| HARRISON, Steven Richard | Director | 2009-08-28 | 2011-10-11 |
| HAYES, Paul Andrew | Director | 2017-05-01 | 2020-02-04 |
| HUNNYBALL, Ian Michael, Professor | Director | 2007-03-01 | 2009-03-11 |
| JONES, Nicholas Vaughan | Director | 2009-11-27 | 2014-11-12 |
| LEACH, Andy | Director | 2008-11-26 | 2009-06-18 |
| MACKENZIE, David Arthur | Director | 2011-10-11 | 2011-11-29 |
| MCCONNELL, John Martin | Director | 2011-10-11 | 2014-11-12 |
| MCCONNELL, John | Director | 2010-01-01 | 2010-12-31 |
| MUIR, Ian Stuart | Director | 2014-11-12 | 2017-05-18 |
| PALMER, Jarrett Vincent | Director | 2014-11-12 | 2015-05-28 |
| PARKER, John Francis | Director | 2009-03-01 | 2011-10-11 |
| PLUTA, Bernard | Director | 2021-04-09 | 2022-01-07 |
| QUICK, Mark Royston | Director | 2020-06-15 | 2022-01-07 |
| RANKIN, Alan | Director | 2004-08-16 | 2006-10-09 |
| SIMS, Adam Duncan | Director | 2004-08-16 | 2010-12-31 |
| WARD, Iain Stuart | Director | 2014-11-12 | 2015-11-02 |
| WILKINSON, Craig | Director | 2004-08-31 | 2008-11-26 |
| YURKWICH, Adrian | Director | 2011-10-11 | 2011-11-29 |
| EVERDIRECTOR LIMITED | Corporate Nominee Director | 2004-07-23 | 2004-08-16 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Xiaoqiang Lou | Individual | Shares 75–100%, Voting 75–100%, Appoints directors | 2025-03-05 | Active |
| Bei Zheng | Individual | Shares 75–100%, Voting 75–100%, Appoints directors | 2025-03-05 | Active |
| Boliang Lou | Individual | Shares 75–100%, Voting 75–100%, Appoints directors | 2025-03-05 | Active |
| Pharmaron Uk Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2022-01-07 | Ceased 2025-03-05 |
| Consort Medical Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2020-10-20 | Ceased 2022-01-07 |
| Consort Medical Limited | Corporate entity | Shares 75–100%, Voting 75–100% | 2016-04-06 | Ceased 2020-10-20 |
Filing timeline
Last 20 of 274 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-04-28 | SH01 | capital | capital allotment shares |
| 2025-07-29 | CS01 | confirmation-statement | confirmation statement with updates |
| 2025-07-28 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2025-07-28 | PSC01 | persons-with-significant-control | notification of a person with significant control |
| 2025-07-28 | PSC01 | persons-with-significant-control | notification of a person with significant control |
| 2025-07-28 | PSC01 | persons-with-significant-control | notification of a person with significant control |
| 2025-07-28 | SH01 | capital | capital allotment shares |
| 2025-06-18 | AA | accounts | accounts with accounts type full |
| 2024-11-08 | MR04 | mortgage | mortgage satisfy charge full |
| 2024-08-12 | SH01 | capital | capital allotment shares |
| 2024-07-17 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-06-03 | AA | accounts | accounts with accounts type full |
| 2023-09-20 | AA | accounts | accounts with accounts type full |
| 2023-07-19 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-07-17 | AD04 | address | move registers to registered office company with new address |
| 2022-12-30 | AA | accounts | accounts with accounts type full |
| 2022-10-21 | CH03 | officers | change person secretary company with change date |
| 2022-10-21 | CH01 | officers | change person director company with change date |
| 2022-10-20 | CH01 | officers | change person director company with change date |
| 2022-08-01 | CS01 | confirmation-statement | confirmation statement with updates |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Credit score requires total assets, working capital, retained earnings proxy, book equity — not present in the latest extracted accounts.
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory
Activity Score not yet computed for this company.